SANTIS PHARMA
0421.562.592 · rovalta.com · 22/09/2026
SANTIS PHARMA
Overview
What does SANTIS PHARMA do?
SANTIS PHARMA is a Public limited company incorporated in 1981. Its registered office is in Thimister-Clermont. It employs on average 33,7 ETP workers (FTE).
4890 Thimister-Clermont · WallonieSee on map
Trend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 17,9 M € | -3.6% | 18,6 M € | – | – | – | |||
| EBITDA | 1,9 M € | +71.1% | 1,1 M € | +138% | 470,5 k € | -3.9% | 489,7 k € | +6.0% | 461,8 k € |
| Operating result | 1,7 M € | +93.4% | 877,2 k € | +95.7% | 448,3 k € | +0.6% | 445,5 k € | +2.6% | 434,4 k € |
| Net result | 1,2 M € | +93.8% | 631,4 k € | +94.1% | 325,2 k € | +3.7% | 313,7 k € | +8.8% | 288,2 k € |
| Balance sheet | |||||||||
| Equity | 640,4 k € | -87.9% | 5,3 M € | +643% | 712,5 k € | +84.0% | 387,2 k € | -1.6% | 393,6 k € |
| Total assets | 8,7 M € | -28.8% | 12,2 M € | +576% | 1,8 M € | -23.0% | 2,3 M € | +6.3% | 2,2 M € |
| Cash | 99,1 k € | -34.1% | 150,3 k € | +21.8% | 123,4 k € | -71.2% | 428,6 k € | +53.5% | 279,3 k € |
| Debts | 8 M € | +16.8% | 6,9 M € | +532% | 1,1 M € | -44.3% | 1,9 M € | +8.0% | 1,8 M € |
| Other | |||||||||
| Workforce | 33,7 ETP | +19.9% | 28,1 ETP | +539% | 4,4 ETP | -25.4% | 5,9 ETP | +5.4% | 5,6 ETP |
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 8 active · 5 ended
Active mandates
Ended mandates
Other companies at this address
| Company | CBE no. |
|---|---|
GENERATION 2000● Active | 0432.862.104 |
La Grande Pharmacie● Active | 0402.353.129 |
PHARMACIE DOUCET-STAS● Active | 0859.769.297 |
PHARMACIE LARDINOIS● Active | 0420.259.329 |
| 0402.307.894 | |
PHARMAEXPRESS● Active | 0743.800.651 |
PHARMA FUTUR● Active | 0787.394.827 |
V-IMMO● Active | 0461.767.213 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 28/04/2026 | 19/05/2025 | 16/07/2024 | 22/05/2023 | 15/07/2022 | 10/06/2021 |
| General meeting | 27/04/2026 | 28/04/2025 | 25/06/2024 | 09/05/2023 | 21/06/2022 | 01/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
20 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/12/2025 | 27/04/2026 | 28/04/2026 | French | |
| Full model | 31/12/2024 | 28/04/2025 | 19/05/2025 | French | |
| Abridged model | 31/12/2023 | 25/06/2024 | 16/07/2024 | French | |
| Abridged model | 31/12/2022 | 09/05/2023 | 22/05/2023 | French | |
| Abridged model | 31/12/2021 | 21/06/2022 | 15/07/2022 | French | |
| Abridged model | 31/12/2020 | 01/06/2021 | 10/06/2021 | French | |
| Abridged model | 31/12/2019 | 30/06/2020 | 28/08/2020 | French | |
| Abridged model | 31/12/2018 | 29/06/2019 | 10/08/2019 | French | |
| Abridged model | 31/12/2017 | 30/06/2018 | 23/08/2018 | French | |
| Abridged model | 31/12/2016 | 30/06/2017 | 29/08/2017 | French | |
| Abridged model | 31/12/2015 | 30/06/2016 | 20/08/2016 | French | |
| Abridged model | 31/12/2014 | 30/06/2015 | 03/08/2015 | French | |
| Abridged model | 31/12/2013 | 30/06/2014 | 20/08/2014 | French | |
| Abridged model | 31/12/2012 | 30/06/2013 | 23/08/2013 | French | |
| Abridged model | 31/12/2011 | 30/06/2012 | 28/08/2012 | French | |
| Abridged model | 31/12/2010 | 30/06/2011 | 02/08/2011 | French | |
| Abridged model | 31/12/2009 | 30/06/2010 | 18/07/2010 | French | |
| Abridged model | 31/12/2008 | 30/06/2009 | 07/08/2009 | French | |
| Abridged model | 31/12/2007 | 30/06/2008 | 15/08/2008 | French | |
| Abridged model | 31/12/2006 | 30/06/2007 | 28/08/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 2,5 M€ and 5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 8 active · 5 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Registered office09/09/2026CHANGEMENT DE SIEGE SOCIAL
- Mandates09/09/2025DEMISSIONS, NOMINATIONS
- Mandates29/07/2024DENOMINATION
- Restructuring23/07/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring27/05/2024RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Mandates30/01/2024SIEGE SOCIAL - DEMISSIONS, NOMINATIONS
- Capital / shares29/07/2021STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - CAPITAL, ACTIONS
- Mandates25/06/2021DEMISSIONS, NOMINATIONS
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 20251,2 M €↑
- 2024Annual accounts 2024631,4 k €↑
- 2024Name changeSANTIS PHARMA
- 2023Annual accounts 2023325,2 k €↑
- 2022Annual accounts 2022313,7 k €↑
- 2021Annual accounts 2021288,2 k €
- 2021Name changePHARMACIE BUSTIN
- 01/04/1981IncorporationPublic limited company